Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977 August; 70(8): 521–525.
PMCID: PMC1543291

The immune response in hepatic cirrhosis: animal and human studies.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (799K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Andersson J, Melchers F, Galanos C, Lüderitz O. The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med. 1973 Apr 1;137(4):943–953. [PMC free article] [PubMed]
  • Balfour WE, Comline RS. Acceleration of the absorption of unchanged globulin in the new-born calf by factors in colostrum. J Physiol. 1962 Feb;160(2):234–257. [PubMed]
  • Bash JA, Waksman BH. The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. J Immunol. 1975 Feb;114(2 Pt 2):782–787. [PubMed]
  • Bjorneboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet. 1972 Jan 8;1(7741):58–60. [PubMed]
  • BRAUDE AI, CAREY FJ, ZALESKY M. Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate. J Clin Invest. 1955 Jun;34(6):858–866. [PMC free article] [PubMed]
  • Chisari FV, Edgington TS. Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med. 1975 Nov 1;142(5):1092–1107. [PMC free article] [PubMed]
  • Cooperband SR, Badger AM, Davis RC, Schmid K, Mannick JA. The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro. J Immunol. 1972 Jul;109(1):154–163. [PubMed]
  • DeHoratius RJ, Strickland RG, Williams RC., Jr T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol. 1974 Apr;2(3):353–360. [PubMed]
  • Folch H, Waksman BH. Regulation of lymphocyte responses in vitro. V. Suppressor activity of adherent and nonadherent rat lymphoid cells. Cell Immunol. 1973 Oct;9(1):12–24. [PubMed]
  • Hsu CC, Leevy CM. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol. 1971 May;8(5):749–760. [PubMed]
  • Lee AK, Mackay IR, Rowley MJ, Yap CY. Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment. Clin Exp Immunol. 1971 Oct;9(4):507–518. [PubMed]
  • MacSween RN, Thomas MA. Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin Exp Immunol. 1973 Dec;15(4):523–533. [PubMed]
  • McLean EK, McLean AE, Sutton PM. Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Pathol. 1969 Oct;50(5):502–506. [PubMed]
  • Murgita RA, Tomasi TB., Jr Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response. J Exp Med. 1975 Feb 1;141(2):269–286. [PMC free article] [PubMed]
  • Nielsen KH, White RG. Effect of host decomplementation on homeostasis of antibody production in fowl. Nature. 1974 Jul 19;250(463):234–236. [PubMed]
  • Potter BJ, Elias E, Jones EA. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med. 1976 Sep;88(3):427–439. [PubMed]
  • Simjee AE, Hamilton-Miller JM, Thomas HC, Brumfitt W, Sherlock S. Antibodies to Escherichia coli in chronic liver diseases. Gut. 1975 Nov;16(11):871–875. [PMC free article] [PubMed]
  • Taylor RB, Wortis HH. Thymus dependence of antibody response: variation with dose of antigen and class of antibody. Nature. 1968 Nov 30;220(5170):927–928. [PubMed]
  • Thomas HC, Freni M, Sanchez-Tapias J, de Villiers D, Jain S, Sherlock S. Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol. 1976 Nov;26(2):222–227. [PubMed]
  • Thomas HC, Holden R, Jones JV, Peacock DB. Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis. Gut. 1976 Nov;17(11):844–848. [PMC free article] [PubMed]
  • Thomas HC, McSween RN, White RG. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet. 1973 Jun 9;1(7815):1288–1291. [PubMed]
  • Thomas HC, Singer CR, Tilney NL, Folch H, MacSween RN. The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Clin Exp Immunol. 1976 Dec;26(3):574–582. [PubMed]
  • Triger DR, Alp MH, Wright R. Bacterial and dietary antibodies in liver disease. Lancet. 1972 Jan 8;1(7741):60–63. [PubMed]
  • Warshaw AL, Walker WA, Cornell R, Isselbacher KJ. Small intestinal permeability to macromolecules. Transmission of horseradish peroxidase into mesenteric lymph and portal blood. Lab Invest. 1971 Dec;25(6):675–684. [PubMed]
  • White RG, Nielsen KH. Interactions between the immunological responses of a thymus-independent antigen (Salmonella adelaide O antigen) with a thymus-dependent antigen (sheep erythrocytes) in the adult bird. Immunology. 1975 May;28(5):959–972. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press